Axogen, Inc. — Director's Dealing 2022

Jul 20, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2022-07-18

Reporting Person: Billet Isabelle (Chief Strategy and BD Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-07-18	Common Stock	A	2571	—	Acquired	24340	Direct
2022-07-19	Common Stock	D	751	$8.40	Disposed	24242	Direct

Footnotes

F1: This reflects the number of shares that vested as of July 18, 2022 upon the attainment of certain performance criteria.

F2: The reported shares were sold, in compliance with company policy as to delivery of compensation based equity, with proceeds from such being used to cover the Reporting Person's tax withholding liability in connection with a portion of a performance stock award that vested on July 19, 2022.